Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 12 | Longs Won 2/12 16% | Profit Factor 0.78 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $25,391.53 |
| Average Win $33,379.6 | Best Trade (Jul 23) $53,577.11 | Sharpe Ratio -15.19 |
| Average Loss -$8,605.21 | Worst Trade (Feb 28) -$60,314.13 | Z-Score 3.77 (99.98%) |
| Commissions $0 | Avg. Trade Length 1m 2w 1d | Expectancy -$1,607.74 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 9 | 8 | 8 | 7 | 6 | 5 | 4 | 3 | 2 | 1 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
TSHA Taysha Gene Therapies Inc. | 14,781.53 | $101,401.27 | $80,707.13 | - | -$20,694.14 | -20.41% | -1.444% |